Tomasz Mierzwa
Overview
Explore the profile of Tomasz Mierzwa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bebyn M, Sledzinska P, Wojtysiak J, Jozwicki W, Mierzwa T, Dziedzic J, et al.
Eur J Obstet Gynecol Reprod Biol
. 2021 Dec;
268:129-134.
PMID: 34915392
Objectives: To evaluate the incidence of HPV infection, and the frequency of the various genotypes, using mRNA and DNA testing; to assess their relationship with the cervical lesions and women's...
2.
Szczerba E, Kaminska K, Mierzwa T, Misiek M, Kowalewski J, Lewandowska M
Genes (Basel)
. 2021 Apr;
12(4).
PMID: 33918338
(1) Background: Although, in the mutated detected in the Polish population of patients with breast cancer, there is a large percentage of recurrent pathogenic variants, an increasing need for the...
3.
Huzarski T, Byrski T, Gronwald J, Gorski B, Domagala P, Cybulski C, et al.
J Clin Oncol
. 2013 Aug;
31(26):3191-6.
PMID: 23940229
Purpose: To estimate 10-year overall survival (OS) rates for patients with early-onset breast cancer, with and without a BRCA1 mutation, and to identify prognostic factors among those with BRCA1-positive breast...
4.
Janiszewska H, Haus O, Lauda-Swieciak A, Bak A, Mierzwa T, Sir J, et al.
Hered Cancer Clin Pract
. 2010 Mar;
4(1):15-9.
PMID: 20222998
The frameshift NOD2 gene mutation 3020insC is predominantly associated with Crohn's disease, but predisposes to many types of common cancers as well. We studied the frequency of this mutant NOD2...
5.
Byrski T, Gronwald J, Huzarski T, Grzybowska E, Budryk M, Stawicka M, et al.
J Clin Oncol
. 2009 Dec;
28(3):375-9.
PMID: 20008645
Purpose: To estimate the rate of pathologic complete response (pCR) to neoadjuvant chemotherapy in BRCA1 mutation carriers according to chemotherapy regimen. Patients And Methods: From a registry of 6,903 patients,...
6.
Kowalski W, Mierzwa T, Grabiec M, Laskowski R, Walentowicz M
Ginekol Pol
. 2006 Sep;
77(5):376-82.
PMID: 16958227
Objectives: There are several challenges in the diagnosis of breast cancer in young women. Special consideration must be given to the woman's fertility and body image issues, but the difficulty...
7.
Mierzwa T, Grabiec M, Walentowicz M
Ginekol Pol
. 2006 Jan;
76(9):693-8.
PMID: 16417080
Objectives: Kujawsko-pomorskie province is a region with high morbidity and death-rate from uterine cervix cancer. One of the methods of improve this situation is to perform prophylactic physical examinations to...
8.
Mierzwa T, Grabiec M
Ginekol Pol
. 2005 Sep;
76(6):457-64.
PMID: 16149263
Objectives: Kujawsko-pomorskie province is a region with high morbidity and mortality from breast cancer. One of the method of improving this situation is to perform prophylactic medical examinations aiming to...
9.
Mierzwa T, Kowalski W, Grabiec M, Laskowski R, Walentowicz M
Ginekol Pol
. 2005 Sep;
76(5):377-84.
PMID: 16145857
Objectives: Kujawsko-pomorskie province is a region with high morbidity and death-rate from breast cancer. One method of detected less advanced forms of breast cancer and increased number of patients with...
10.
Grabiec M, Nowicki P, Walentowicz M, Grezlikowska U, Mierzwa T, Chmielewska W
Ginekol Pol
. 2005 Sep;
76(5):371-6.
PMID: 16145856
Objectives: Serum CA-125 is of value in differential diagnosis of benign and malignant adnexal masses, especially in postmenopausal women. In ovarian cancer preoperative CA-125 levels are related to tumor stage,...